CALSTRYN
Live / Applied — Third extension granted (statement of use) (as of 23 Oct 2025)
What this means for you
Not registered yet, but its 26 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97908767
- Mark type
- Stylized text
- Filed
- 26 Apr 2023
- Published for opposition
- 27 Feb 2024
- Attorney of record
- Alisa C. Simmons
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic test media in the form of chemical agents for diagnosing thyroid cancer; medical diagnostic test chemical agents administered to patients for use in the field of oncology
Owner
- Exela Holdings, Inc., Lenoir, NC, US
- Exela Holdings, Inc., Lenoir, NC, US
Prosecution history
- 23 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2025 — SOU EXTENSION 3 GRANTED
- 22 Oct 2025 — SOU EXTENSION 3 FILED
- 22 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Apr 2025 — SOU EXTENSION 2 GRANTED
- 22 Apr 2025 — SOU EXTENSION 2 FILED
- 22 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Oct 2024 — SOU EXTENSION 1 GRANTED
- 23 Oct 2024 — SOU EXTENSION 1 FILED
- 23 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Feb 2024 — PUBLISHED FOR OPPOSITION